BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 18662521)

  • 21. An evaluation of low-dose simvastatin in achieving LDL goal: a retrospective chart review.
    Schnee DM; Bogdanski L; Zaiken K; McCloskey WW
    Manag Care Interface; 2007 May; 20(5):53-7. PubMed ID: 17626594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events.
    LaRosa JC; Pedersen TR; Somaratne R; Wasserman SM
    Am J Cardiol; 2013 Apr; 111(8):1221-9. PubMed ID: 23375731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins' role in prevention. Do statins have a role in primary prevention of cardiovascular events?
    Can Fam Physician; 2004 Aug; 50():1091. PubMed ID: 15455806
    [No Abstract]   [Full Text] [Related]  

  • 24. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 26. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L; Pedro-Botet J; Civeira F
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract]   [Full Text] [Related]  

  • 27. Newer, lower, better? Lipid drugs and cardiovascular disease--the continuing story.
    Wierzbicki AS
    Int J Clin Pract; 2007 Jul; 61(7):1064-7. PubMed ID: 17577288
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for lipids.
    Treat Guidel Med Lett; 2011 Mar; 9(103):13-20. PubMed ID: 21350395
    [No Abstract]   [Full Text] [Related]  

  • 29. Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Robinson JG; Stone NJ
    Am J Cardiol; 2006 Nov; 98(10):1405-8. PubMed ID: 17134640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital.
    Spighi A; Tartagni E; D'Addato S; Dormi A; Borghi C
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):270-5. PubMed ID: 22728834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
    Whayne TF
    Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks and benefits of statins in lupus erythematosus.
    Noël B
    Arch Intern Med; 2004 Jan; 164(1):107-8. PubMed ID: 14718334
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Muscle-sparing' statins: preclinical profiles and future clinical use.
    Pfefferkorn JA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):245-52. PubMed ID: 19333882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 37. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
    Klose G
    MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
    [No Abstract]   [Full Text] [Related]  

  • 38. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

  • 40. Study stirs debate about statin use in those without high cholesterol.
    Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.